revoglip

Revoglip is an oral antidiabetic medication containing the active ingredient **teneligliptin**, used primarily for the management of type 2 diabetes mellitus. Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor (also known as a "gliptin"), which works by increasing the release of insulin from the pancreas and reducing glucagon levels, thereby lowering fasting and postprandial blood glucose. It is typically prescribed when diet, exercise, and/or other antidiabetic agents fail to control blood sugar adequately. Revoglip is available alone (as Revoglip 20 Tablet) or in combination with metformin (as Revoglip-M).

Brand names

Revoglip

Other names

revoglip